Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stefania Gastaldi
Observed name:
GASTALDI, Stefania
Institution:
University of Turin
Observed institutions:
Azienda Ospedaliero Universitaria San Giovanni Battista,
Candiolo Cancer Institute,
University of Turin,
University of Genoa
OpenAlex ID:
A5111838340
Hemopexin Prevents Endothelial Damage and Liver Congestion in a Mouse Model of Heme Overload
2008
·
Francesca Vinchi
, Stefania Gastaldi
, et al.
·
American Journal Of Pathology
·
133
PDF
Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2011
·
Francesco Galimi
, Davide Torti
, et al.
·
Clinical Cancer Research
·
129
PDF
Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction
2009
·
Andrea Bertotti
, Mike F. Burbridge
, et al.
·
Science Signaling
·
106
PDF
The Met oncogene and basal-like breast cancer: another culprit to watch out for?
2010
·
Stefania Gastaldi
, Paolo M Comoglio
, et al.
·
Breast Cancer Research
·
82
PDF
Inhibition of Src Impairs the Growth of Met-Addicted Gastric Tumors
2010
·
Andrea Bertotti
, Cecilia Bracco
, et al.
·
Clinical Cancer Research
·
48
PDF
Decrease of Serotonin Transporters in Blood Platelets after Epileptic Seizures
2005
·
Aroldo Cupello
, Emilio Favale
, et al.
·
Neurochemical Research
·
28
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors
2011
·
Davide Torti
, Francesco Sassi
, et al.
·
International Journal of Cancer
·
23
PDF
Supplementary Figure S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S3 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Materials and Methods from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S2 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S1 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S7 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Data from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
PDF
Supplementary Table S4 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S6 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S5 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S4 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S6 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S2 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Supplementary Table S7 from Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
2023
·
Francesco Galimi
, Davide Torti
, et al.
Met as a potential therapeutic target in basal-like breast cancer
2010
·
GASTALDI, Stefania
, BERTOTTI, Andrea
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition
2010
·
TORTI, DAVIDE
, BERTOTTI, Andrea
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective
2009
·
Stefania Gastaldi
, Andrea Bertotti
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Show more works
View as search
Works count:
24
Citation count:
549
H-index:
7
I10-index:
7
Year
Topic
Type